Us2.ai logo — Ultrasound Anyone Anywhere

Us2.ai

Ultrasound Anyone Anywhere

Founded 2017 Singapore Singapore 30 employees Series A Total: $15.00M AI, Digital Health +3

General Information

Company Name Us2.ai
Founded Year 2017
Location Singapore Singapore
Employees 30
Industries AI, Digital Health, Health Care +2
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Us2.ai. To contact Us2.ai, visit us2.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Us2.ai compare?

A PDF of Us2.ai and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Us2.ai soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Us2.ai

Us2.ai is a Singapore-based startup founded in 2017 with the catchy slogan "Ultrasound Anyone Anywhere." They are revolutionizing the healthcare industry by leveraging AI to democratize echocardiograms, aiming to improve patient outcomes and expand healthcare access. Their recent milestone includes a significant $15.00M Series A investment on 14 April 2022, with a diverse group of investors including EDBI, FJ Labs, Pappas Capital, Peak XV Partners, HEAL Partners, Partech Ventures, IHH Healthcare Berhad, and Sequoia Capital.

Us2.ai's vision is to create a future where everyone has equal access to high-quality and affordable echo analysis, regardless of their geographic location or available resources. By focusing on the healthcare industry, the startup is strategically positioned to make a significant impact through technological innovation and inclusive healthcare solutions.

Business keywords: Echocardiography, POCUS, Machine learning, Ultrasound, Heart disease, Heart Failure, Medical technology, Digital health

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $15.00M 8
EDBI, FJ Labs +6
14 Apr 2022

Us2.ai Alternatives & Competitors

View All Alternatives
Us2.ai vs
Ligence
Ligence Lithuania

Echocardiography workflow that makes sense

Seed
30 employees
AI, Analytics
Us2.ai vs

Using Artificial Intelligence (AI) to create 3D volumetric measurements from standard 2D Echo images...

Post-IPO Equity
18 employees
Analytics, Biotechnology
Us2.ai vs
BioVentrix
BioVentrix United States

BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our missi...

Series A
17 employees
Biotechnology, Health Care

FAQ About Us2.ai

Ultrasound Anyone Anywhere
Us2.ai was founded in 2017.
Us2.ai is headquartered in Singapore.
Us2.ai operates in AI, Digital Health, Health Care, Medical Devices and Machine Learning. Its work centres on Echocardiography, POCUS, Machine learning and Ultrasound.
Us2.ai has approximately 30 employees.
Us2.ai has completed 1 funding round, raising a total of $15.00M. The latest funding stage is Series A.
Top alternatives and competitors to Us2.ai include Ligence, Ventripoint Diagnostics Ltd., BioVentrix, CureMetrix, PONS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Us2.ai and Ligence are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Us2.ai, https://bouncewatch.com/company/us2ai, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes